Clinicopathological Features and Prognostic Implication of Gastric Carcinoma with Lymphoid Stroma

Table 5

The prognostic implications of gastric carcinoma with lymphoid stroma.

	Number of subsets	Fixed effect (95% CI)	Heterogeneity test ( value)	Random effect (95% CI)	Egger’s test ( value)
GCLS vs. non-GCLS
Overall	6	0.854 [0.767, 0.951]	<0.001	0.500 [0.305, 0.821]	0.023
EGC	1	1.022 [0.788, 1.325]	1.000	1.022 [0.788, 1.325]	—
AGC	1	0.863 [0.765, 0.972]	1.000	0.863 [0.765, 0.972]	—
EBVaGC	2	0.090 [0.025, 0.319]	0.884	0.090 [0.025, 0.319]	—
EBV+ vs. EBV- in GCLS	2	0.573 [0.305, 1.076]	0.147	0.477 [0.160, 1.425]	—

CI, confidence interval; GCLS, gastric carcinoma with lymphoid stroma; EGC, early gastric carcinoma; AGC, advanced gastric carcinoma; EBV, Epstein-Barr virus.